Orchid Pharma: Amalgamation with Dhanuka Labs Effective, MoA Capital Clause Amended

Orchid Pharma Ltd announced that the Scheme of Amalgamation of Dhanuka Laboratories Limited has become effective from July 10, 2026. Consequently, Dhanuka Laboratories Limited stands dissolved without winding up. The authorized share capital of Orchid Pharma has been increased to ₹164.51 crore. A record date of July 23, 2026, has been fixed for allotting shares to Dhanuka Labs' shareholders. The share exchange ratio is 161 Orchid Pharma shares for every 5 Dhanuka Labs shares.